An IRB Perspective on Improving Informed Consent

Author: Julie Blasingim, MBA, CIP; Sandra “SAM” Sather, MS, BSN, RN, CCRC, CCRA
Publication: Clinical Researcher

Advarra Vice President of Corporate Quality Assurance, Training, and Process Improvement Julie Blasingim co-authored the article An IRB Perspective on Improving Informed Consent in Clinical Researcher.

The informed consent process is essential to the ethical conduct of research on new medicinal products, therapies, and approaches to improving healthcare. The investigator can use various tools to optimize this process, but the most important feature of informed consent is the investigator’s commitment to high standards in its conduct. This article looks at the institutional review board’s (IRB’s) perspective on the informed consent process, and how electronic informed consent is propelling human research forward.

View Abstract

Back to Resources